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The mouth and oropharynx cancer is the 6th most common type of cancer in the world. 
The treatment may involve surgery, chemotherapy and radiotherapy. More than 50% of 
drugs against cancer were isolated from natural sources, such as Catharanthus roseus 
and epipodophyllotoxin, isolated from Podophyllum. The biggest challenge is to maximize 
the control of the disease, while minimizing morbidity and toxicity to the surrounding 
normal tissues. The Erythroxylum suberosum is a common plant in the Brazilian Cerrado 
biome and  is popularly known as “cabelo-de-negro”. The objective of this study was 
to evaluate the cytotoxic activity of Erythroxylum suberosum plant extracts of the 
Brazilian Cerrado biome associated with radiotherapy in human cell lines of oral and 
hypopharynx carcinomas. Cells were treated with aqueous, ethanolic and hexanic 
extracts of Erythroxylum suberosum and irradiated at 4 Gy, 6 Gy and 8 Gy. Cytotoxicity 
was evaluated by MTT assay and the absorbance was measured at 570 nm in a Beckman 
Counter reader. Cisplatin, standard chemotherapy, was used as positive control. The use 
of Erythroxylum suberosum extracts showed a possible radiosensitizing effect in vitro 
for head and neck cancer. The cytotoxicity effect in the cell lines was not selective 
and it is very similar to the effect of standard chemotherapy. The aqueous extract of 
Erythroxylum suberosum, combined with radiotherapy was the most cytotoxic extract 
to oral and hypopharynx carcinomas. 
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Introduction 
Cancer is a leading cause of mortality worldwide. 
Among all subtypes, the carcinoma of mouth and pharynx, 
together, stands out as the sixth most common (1). In South 
America and Caribbean, cancers of mouth and pharynx 
rank fifth among men and sixth among women (1). A high 
incidence rate for oral and larynx cancer is observed in 
Brazil, with up to 20,000 new cases per year (2). Despite 
all the innovations, the life expectancy of patients still 
remains around 50%, after 5 years of cancer diagnosis (3). 
There are many approaches adopted to deal with cancer, but 
they are always aggressive and come along with a number 
of side effects, which significantly reduces the patient’s 
quality of  life (3). The main treatment methods for head 
and neck cancer are surgery, radiotherapy, chemotherapy 
or a combination of two or more of these techniques (4). 
Radiotherapy is indicated as a treatment for head and neck 
cancer, especially in advanced cases, alone or combined 
(4,5). The search for new therapies for cancer treatment 
should look for a balance between the ability of patients 
to tolerate the side effects of treatment and the potential 
toxicity that may occur later (6). Plant-derived products are 
excellent sources for discovery and development of new 
anticancer agents since the 60’s, with the first researches 
on epipodophyllotoxin and its derivatives as cytotoxic 
agents, until nowadays, with the study of vinca alkaloids, 
vinblastine, vincristine, epipodophyllotoxin and taxanes, 
which are natural sources of drugs with activity against 
cancer (7). Several studies have been conducted using 
products derived from plants, which are excellent sources 
for the development of new anticancer agents (8,9). Tokgun 
et al. (10) pointed out that treatment with plant derivatives 
have fewer side effects than synthetic drugs. Therefore, the 
search for derivatives from natural compounds to treat 
cancer seems promising. Recent studies with plant extracts 
from different regions, came up highlighting the cytotoxic 
effects in cell lines of different cancer types, like breast, 
esophagus, stomach, lung and others (10-12).
Regarding head and neck tumors, in the past 20 
years, chemoradiotherapy was established as the 
most conservative treatment (13). The combination of 
radiotherapy with natural extracts also appears to be an 
important tool in the treatment of such tumors. Kotowski 
et al. (14) studied the effect of sulforaphane added to 
radiation exposures in cell lines of head and neck cancer. The 
experiment showed that the combination of sulforaphane, 
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a compound derived from broccoli and other cruciferous 
vegetables, and radiation leads to a stronger inhibition of 
cell proliferation and clonogenic survival compared to the 
use of single treatments. The Cerrado biome is the second 
largest one in Brazil, extending for about 2 million square 
kilometers (15), but it appears that little is known about the 
biological potential of this biome. In the Brazilian Cerrado 
there are promising possibilities to be investigated. De 
Mesquita et al. (8) tested 412 extracts of 50 plants from 
Cerrado used in traditional medicine, in tumor cell lines 
from human cervix carcinoma, melanoma, leukemia and 
brain. The study showed an antiproliferative potential for 
28 extracts.
The Erythroxylum suberosum (E. suberosum) is a 
common plant in the Cerrado biome, especially in the 
State of Mato Grosso do Sul, and it is popularly known 
by ‘’cabelo-de-negro”. A supra-additive cytotoxic effect 
in head and neck carcinoma cell lines has already been 
shown by Erythroxylum suberosum followed by irradiation 
with a single dose of 2 Gy (16). In view of the biological 
potential of plants from the Cerrado biome, this paper 
aims to evaluate the cytotoxic activity of Erythroxylum 
suberosum plant extracts combined with radiotherapy 
in human cell lines of oral and hypopharynx carcinomas.
Material and Methods 
Plant Material and Extraction 
For the experiments were used aqueous, ethanolic 
and hexanic extracts from the leaves of Erythroxylum 
suberosum A. St.-Hil. collected from the Cerrado biome in 
the city of Brasília, Brazil and its surroundings. Different 
types of solvent can separate the substances in the plant 
according to their polarity, so the hexane extract has the 
most non-polar compounds and the aqueous extract the 
polar substances. The voucher herbarium specimens were 
deposited in the herbarium of the University of Brasilia, 
Brazil (UB 2192). All necessary permits were obtained 
previously of this experimental study. 
To obtain the extracts, the leaves of E. suberosum passed 
drying process at room temperature and spraying process. 
Subsequently, they were submitted to extraction by passive 
maceration, using hexane solvent followed by ethanol, 
to obtain the hexane and ethanol extracts. The obtained 
extractive solutions were concentrated to dryness under 
vacuum, at about 40 °C in rotaevaporator. The aqueous 
extract was obtained by infusing the dried and pulverized 
leaves in distilled water (3.0 L) at approximately 70 °C, 
cooled to approximately 40 °C and subjected to filtration. 
The resulting extraction solution was maintained at -20 
°C and subjected to lyophilization process, producing a 
powder that maintains the active ingredient for a long 
period of time.
Cell Culture 
Cell lines of oral squamous cell carcinoma (SCC-9), 
hypopharynx squamous cell carcinoma (FaDu), and human 
keratinocyte (HaCaT) were used. All cell lines are described 
in ATCC (American Type Culture Collection). The cells were 
stored in an incubator at 37 °C and 5% of CO2. For FaDu cells 
and HaCaT the cell culture medium was Dulbecco’s Modified 
Eagle Medium (DMEM, Sigma-Aldrich) supplemented 
with fetal bovine serum at 10% and 1% penicillin and 
streptomycin. For cultivation of SCC-9 was used DMEM/
F12 ratio (1:1) supplemented with the above supplements 
and hydrocortisone. For trypsinization of the cells was used 
0.25% trypsin  with 0.03% EDTA. 
Cytotoxicity assay 
SCC-9, FaDu, HaCaT cell lines were plated at a 
concentration of 5x10³ cells per well in 96-well plates and 
after 24 h treated with the extracts at a concentration of 
500 µg/mL, as described in a former study (16). Cisplatin 
(Citoplax, 1 mg/mL; Bergamo, Taboão da Serra, SP, Brazil) 
at a 50 µg/mL was used as a positive control. For negative 
control, the cells were treated only with the corresponding 
solvent used for dilution of the extracts (milliq water for 
aqueous extract and DMSO/ethanol 2:3 for hexanic and 
ethanolic extracts). After 24 h of treatment the culture with 
the extract was aspirated and the cells were maintained 
in 100 µL PBS (Phosphate Buffered Saline) for irradiation.
Irradiation 
Irradiation was performed at the Department of 
Radiotherapy- CACON, University Hospital of Brasilia using 
a Siemens Primus Linear Accelerator apparatus (Siemens, 
Germany), in conventional radiation, with 6 mV photon beams 
at fractional doses of 4, 6 and 8 Grays. For irradiation, the 
culture medium with treatment and controls were removed 
and all wells were added with 100 µL of PBS 1x. After 
irradiation, the PBS was removed and cells maintained in 100 
µL of culture medium without any treatment for more 24 h. 
MTT Assay
The cell viability was assessed by MTT test 
[3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium 
bromide], and the absorbance measured by Beckman 
Counter reader at 570 nm (Beckman Coulter Inc., Brea, CA, 
USA). Cells treated only with the suitable solvent for each 
extract and irradiation were considered as negative control 
(100%). All other percentages were calculated compared to 
the control cells. The experiments were performed at least 
three times independently and in triplicate. 
Statistical Analysis 
Statistical analysis was performed using GraphPad 










Prism version 5.0 and applied one-way ANOVA followed 
by Tukey’s multiple comparison test. It was considered 
statistically significant results for p<0.05 compared with 
the control group.
Results 
For oral cancer cell line (SCC-9), cisplatin in combination 
with radiotherapy at the dose of 4 Gy radiation resulted 
in approximately 36% viable cells, while the pretreatment 
with aqueous extract from E. suberosum (ESA) proved to 
be more effective, leaving only 27% viable cells. Similar 
results were found in the combination of ESA with the 
dose of 8 Gy (31% viable cells). Unlike the aqueous extract, 
the pretreatment of SCC-9 with the ethanolic (ESE) and 
hexanic (ESH) extracts, cell viability was about 50%, but the 
results were not considered statistically significant. For the 
ethanol extract of E. suberosum (ESE), the best result was 
under irradiation of 8 Gy, which resulted in approximately 
54% of cytotoxicity, while for the hexane extract of the 
plant (ESH) under irradiation of 4 Gy the result was 63% 
cytotoxicity (Fig. 1). 
The hypopharynx carcinoma cells (FaDu) appear to be 
more sensitive to the combination of E. suberosum extracts 
and the 8 Gy radiation dose. In the other dose only the 
cisplatin/radiotherapy 6 Gy combination showed strong 
toxicity, with only 28.4% viable cells. The aqueous extract 
showed the highest cytotoxic activity, demonstrating 
viability rates corresponding to 34%, 39% and 26% when 
associated with doses of 4 Gy, 6 Gy and 8Gy, respectively. 
For the cells under an 8 Gy radiotherapy, the ethanolic 
extract (ESE) also showed high toxicity, resulting in a 
reduction in the number of viable cells (28%). This behavior 
was very similar to the one observed in cells treated with 
chemotherapy, 22% cell viability. Only ESH did not show 
results of toxicity considered statistically significant under 
8 Gy irradiation (Fig. 2). 
All treatments were aggressive to the keratinocyte cell 
line (HaCaT). The results that showed the highest percentage 
of cell viability were the ESH treatments, approximately 
47%, under 4 Gy radiation and ESE 49% when associated 
with 6 Gy radiation. Previous treatments of cisplatin and 
the aqueous extract of E. suberosum associated with the 
4 Gy dose, had very similar cytotoxic activity, resulting in 
approximately 73% of cell death. Among all treatments, 
cisplatin was less toxic under 8 Gy radiation with about 
27% viable cells (Fig. 3).
Discussion
This study underlines the important biological potential 
of E. suberosum associated with radiation for oral cancer 
treatment. Here was demonstrated that FaDu (hypopharynx 
carcinoma cell line) and SCC-9 (oral cancer cell line) treated 
with ESA presented similar percentage of cell toxicity (74%). 
The FaDu cells were exposed to 8 Gy of irradiation, while 
SCC-9 cells were exposed to a lower radiation dosage, only 
4 Gy. Such behavior allows to infer that there is difference 
in behavior between head and neck carcinoma cell lines, 
and the combination treatment extract of E. suberosum 
and radiotherapy was more effective for the oral carcinoma 
cell line (SCC-9). In a similar manner, data from the 
MACH-NC Collaborative Group indicated that concomitant 
chemotherapy and radiotherapy provided a survival benefit 
Figure 1. Cytotoxicity in oral carcinoma cells (SCC-9) treated with 
aqueous (ESA), ethanolic (ESE) and hexanic (ESH) extracts of 
Erythroxylum suberosum and irradiated with 4 Gy, 6 Gy and 8 Gy. 
Control: solvent extracts (milliq water to aqueous extract and DMSO/
Ethanol for ethanolic and hexanic) and radiation. The absorbance 
of control cells was stabilized as 100% viability. The results are 
representative of at least three independent experiments in triplicate 
and show the mean±SD. *p<0.05 vs. control.
Figure 2. Cytotoxicity in hypopharynx carcinoma cells (FaDu) treated 
with aqueous (ESA), ethanolic (ESE) and hexanic (ESH) extracts of 
Erythroxylum suberosum and irradiated with 4 Gy, 6 Gy and 8 Gy. 
Control: solvent extracts (milliq water to aqueous extract and DMSO/
Ethanol for ethanolic and hexanic) and radiation. The absorbance 
of control cells was stabilized as 100% viability. The results are 
representative of at least three independent experiments in triplicate 
and show the mean±SD. *p<0.05 vs. control.























of 8.9% for oral cancer and 4% to hypopharynx tumors. 
This may explain the in vitro results from this study (17). 
The toxicity of the radiation in cells is dose-dependent, 
and has the capacity of inducing sublethal damage sufficient 
to cause apoptosis (18). Bachaud et al. (19) pointed out 
that the combination of chemotherapy and radiotherapy 
has better anti-cancer results than from the treatments 
carried out with radiotherapy only. In order to reduce the 
side effects and toxicity caused by these conventional 
treatments, researchers have sought to exploit new sources 
of treatments, more effective and less toxic compounds. In 
relation to head and neck cancer using this new approach 
with plants, little has been published, but good results have 
emerged. Recently, it was found that plant extracts have 
strong cytotoxic potential in cell lines of various cancer 
types (10,12,19). In addition, there is some evidence that 
the combination of sulforaphane extract with radiotherapy 
showed a better result of cytotoxicity in head and neck 
cancer cell lines than the use of radiotherapy only (14).
The Erythroxylum suberosum has been little studied as an 
antitumor drug, but it has already had its cytotoxic activity 
proven in FaDu cell line, with or without radiotherapy. As 
for the SCC-9 line, only 2 Gy of radiotherapy associated 
to extract was able to induce approximately 50% of cell 
toxicity (16). For Elias et al. (16), hexane extract showed 
the highest toxicity but in this study it was found that 
pretreatment of cells with aqueous (EDA) and ethanol 
(EDE) extracts showed better radiosensitizing effect in 
hypopharynx carcinoma cell lines (FaDu) when associated 
with 8 Gy radiotherapy. This difference may be explained, 
because Elias et al. (16) used only 2 Gy radiation.
On oral carcinoma cell line (SCC-9), EDA associated to 
4 Gy radiation was very cytotoxic, with a better result than 
that observed in cells treated with standard chemotherapy 
(cisplatin) and radiotherapy. The results showed that the 
treatments were not selective for the carcinoma cell lines, 
since they were quite aggressive to all cells, including 
the keratinocytes (HaCaT). Treatment with ESH and 6 Gy 
radiation showed the best result of cell viability for the 
HaCaT cells, approximately 41%, also being better than in 
the conventional treatment with cisplatin which got only 
27% of viable cells under 8 Gy radiation.
The treatment with the aqueous, ethanol and hexane 
extracts of Erythroxylum suberosum in head and neck cancer 
cells showed a possible radiosensitizing effect in vitro. The 
effect of cytotoxicity in the cell lines was not selective 
and very similar to the effect of standard chemotherapy. 
Aqueous extracts of Erythroxylum suberosum were the 
most cytotoxic extracts for oral carcinoma (SCC-9) and 
hypopharynx (FaDu), associated with radiotherapy in 
doses of 4 Gy and 8 Gy, respectively. Among the proposed 
treatments, ethanol extracts of Erythroxylum suberosum 
showed the lowest toxicity to the keratinocyte cell line 
after 6 Gy of radiation. 
Previous study by this group found by HPLC analysis that 
Erythroxylum suberosum extracts present a large number 
of compounds and both extracts, ethanolic and aqueous, 
showed similar compounds in their composition. The 
characteristic UV/Vis spectra of the catechin and flavonoids 
were confirmed by standards. It was possible to identify 
some peaks by comparison of commercial standards, which 
are catechin, epicatechin and rutin (20).
It is important to consider that plant extracts are very 
complex mixtures, presenting a great amount of active 
compounds. This is why this study was done with three 
different crude extracts from each plant species, each one 
with a different polarity. The more polar ones, which are 
the ethanolic and aqueous extracts, are rich in polyphenols. 
Flavonoids are a class of polyphenol compounds, which are 
widespread in the plant kingdom. These compounds present 
several biological activities, including antioxidant (20) and 
radioprotective properties (21). However, a recent report 
demonstrated that soy flavonoids could be a biological 
agent to sensitize cancer to radiation while simultaneously 
protecting surrounding normal tissues (22).
Some of the key components of the plant extracts 
evaluated in this study are triterpenes, fatty acids and 
long chain esters in the hexanic extracts, and flavonoids, 
caffeic acid derivatives and catechins in the ethanolic 
extracts. Specifically, lupeol acetate and α- and β-amyrin 
have been previously isolated from the hexanic extract 
from Pouteria torta (23). Alkaloids were not identified in 
Erythroxylum sp. extracts (23). 
Figure 3. Cytotoxicity in human keratinocyte cells (HaCaT) treated 
with aqueous (ESA), ethanolic (ESE) and hexanic (ESH) extracts of 
Erythroxylum suberosum and irradiated with 4 Gy, 6 Gy and 8 Gy. 
Control: solvent extracts (milliq water to aqueous extract and DMSO/
Ethanol for ethanolic and hexanic) and radiation. The absorbance 
of control cells was stabilized as 100% viability. The results are 
representative of at least three independent experiments in triplicate 
and show the mean±SD. *p<0.05 vs. control










This study emphasizes the important biological potential 
of compounds obtained from the Brazilian Cerrado biome, 
associated with traditional cancer treatments. Thus, there 
is much to be researched to treat cancer, provide greater 
control of the disease and reduce morbidity to surrounding 
normal tissues. 
Resumo 
O câncer de boca e de orofaringe emerge como o 6º tipo de câncer mais 
comum no mundo. O tratamento pode envolver cirurgia, quimioterapia e 
radioterapia. Mais de 50% das drogas com atividade de combate ao câncer 
foram isoladas de fontes naturais, tais como a Catharanthus roseus e a 
epipodofilotoxina, isolada de Podophyllum. O maior desafio é maximizar 
o controle da doença, enquanto minimiza a morbidade e toxicidade para 
os tecidos normais circundantes. O Erythroxylum suberosum é uma planta 
comum no bioma Cerrado brasileiro e é popularmente conhecida como 
“cabelo-de-negro”. O objetivo deste estudo foi avaliar a citotoxicidade 
dos extratos da planta Erythroxylum suberosum do bioma Cerrado 
brasileiro, associados à radioterapia em linhagens celulares humanas de 
carcinomas de língua e de hipofaringe. As células foram tratadas com 
os extratos aquoso, etanólico e hexânico do Erythroxylum suberosum e 
irradiadas com 4 Gy, 6 Gy e 8 Gy. A citotoxidade foi avaliada pelo ensaio 
de MTT e a absorvância foi medida a 570 nm em uma leitora Beckman. 
A cisplatina, quimioterápico padrão, foi utilizada como controle positivo. 
O uso de extratos de Erythroxylum suberosum mostrou potencial efeito 
radiosensibilizante in vitro no câncer de cabeça e pescoço. O efeito da 
citotoxicidade nas linhagens foi de forma não seletiva e muito semelhante 
ao efeito da quimioterapia padrão. O extrato aquoso de Erythroxylum 
suberosum, combinado com radioterapia, foi o extrato mais citotóxico 
para os carcinomas de língua e hipofaringe, associados à radioterapia. 
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